| pubmed-article:11501769 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C0239307 | lld:lifeskim |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C0029246 | lld:lifeskim |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C0035168 | lld:lifeskim |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C1516985 | lld:lifeskim |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C0238122 | lld:lifeskim |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C0010583 | lld:lifeskim |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:11501769 | lifeskim:mentions | umls-concept:C0085752 | lld:lifeskim |
| pubmed-article:11501769 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11501769 | pubmed:dateCreated | 2001-8-14 | lld:pubmed |
| pubmed-article:11501769 | pubmed:abstractText | To investigate the clinical activity and toxicity of a combination chemotherapy consisting of cyclophosphamide (C), adriamycin (A) and cisplatin (P) for patients with primary adenocarcinoma of the Fallopian tube having FIGO stage III-IV disease. | lld:pubmed |
| pubmed-article:11501769 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11501769 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11501769 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11501769 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11501769 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11501769 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11501769 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11501769 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11501769 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11501769 | pubmed:issn | 0392-2936 | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:WagenerD JDJ | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:HerbenM GMG | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:LacaveA JAJ | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:MangioniCC | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:BolinJJ | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:TumoloSS | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:GoupilAA | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:KobierskaAA | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:PecorelliSS | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:ForsBB | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:VermorkenJ... | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:KerbratPP | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:ZanaboniFF | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:VergoteII | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:NooijM AMA | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:CurranDD | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:WagenaarH CHC | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:Bokkel-Huinin... | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:MadronalCC | lld:pubmed |
| pubmed-article:11501769 | pubmed:author | pubmed-author:MarthC HCH | lld:pubmed |
| pubmed-article:11501769 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11501769 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:11501769 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11501769 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11501769 | pubmed:pagination | 187-93 | lld:pubmed |
| pubmed-article:11501769 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:meshHeading | pubmed-meshheading:11501769... | lld:pubmed |
| pubmed-article:11501769 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11501769 | pubmed:articleTitle | Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer. | lld:pubmed |
| pubmed-article:11501769 | pubmed:affiliation | Department of Gynecology, Leiden University Medical Center, The Netherlands. | lld:pubmed |
| pubmed-article:11501769 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11501769 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11501769 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:11501769 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
